I 116th CONGRESS 1st Session H. R. 2917 IN THE HOUSE OF REPRESENTATIVES May 22, 2019 Ms. Gabbard (for herself and Mr. Khanna ) introduced the following bill; which was referred to the Committee on Energy and Commerce , and in addition to the Committee on Education and Labor , for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned A BILL To hold pharmaceutical companies accountable for dubious marketing and distribution of opioid products and for their role in creating and exacerbating the opioid epidemic in the United States.